Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach.
Jessie S LukenSebastien P RitsemaMerel M Van der WalC Ellen Van Der SchootEtiënne A J A RouwetteMasja De HaasMart P JanssenPublished in: Transfusion medicine (Oxford, England) (2022)
Stakeholders believe that a genotyped donor pool can result in a reduction of alloimmunization and higher availability of typed blood products. There are concerns regarding logistics, costs, consent for extended typing, data sharing, privacy issues and donor management. These concerns need to be carefully addressed before further implementation.